How to Help Your Patients Find Depo-SubQ Provera 104 in Stock: A Provider's Guide

Depo-SubQ Provera 104 is not in formal FDA shortage, but the realities of retail pharmacy stocking mean your patients may regularly struggle to fill their quarterly prescription. As a provider, having a clear protocol for these situations prevents gaps in contraceptive coverage and avoids unnecessary patient anxiety. This guide provides a practical workflow you can implement in your practice today.

Why Patients Struggle to Find Depo-SubQ Provera 104

Unlike high-volume oral medications, Depo-SubQ Provera 104 is administered only once every 12–14 weeks. Many retail pharmacies — especially in rural areas — don't stock it routinely and order it only when a patient presents with a prescription. This demand-based model creates frustrating delays for patients who expect same-day pickup.

The situation is compounded by the December 2025 FDA meningioma label update, which has prompted some providers to switch patients to alternatives, further reducing per-pharmacy demand and stocking motivation.

Option 1: Stock Depo-SubQ Provera 104 In Your Office

The most reliable solution is to administer Depo-SubQ Provera 104 directly from in-office stock. Most OB/GYN and women's health practices already do this — patients come in for their scheduled injection appointment and the medication is administered on-site.

Ordering: Contact your pharmaceutical wholesaler (McKesson, AmerisourceBergen, Cardinal Health) or order directly through the Pfizer representative account. Healthcare providers may also request samples through PfizerPro or by calling 800-505-4426.

Storage: Store at controlled room temperature 20°C–25°C (68°F–77°F). Do not freeze.

Billing: Bill under J-code J1051 (medroxyprogesterone acetate for injection) for medical billing. Confirm payer-specific requirements, particularly for endometriosis versus contraceptive indications.

Option 2: Help Patients Find a Nearby Pharmacy That Has It in Stock

When in-office stock is not available or the patient prefers retail pharmacy pickup, medfinder for Providers can streamline the search. medfinder contacts pharmacies near your patient's location to check which ones have Depo-SubQ Provera 104 in stock — so your staff doesn't need to make those calls, and your patient doesn't waste time driving to pharmacies that can't fill the prescription.

Option 3: Coach Patients to Call Their Pharmacy One Week in Advance

A simple but effective intervention: instruct patients to call their pharmacy 7–10 days before their next scheduled injection and ask the pharmacist to place a special order. Most wholesale distributors can deliver within 1–3 business days. This small step eliminates the most common reason for injection delays — the pharmacy being out of stock on the day of the appointment.

Consider including this as a standard discharge instruction or patient handout for all patients on Depo-SubQ Provera 104.

38,404+ patients found their medications in stock

38K+

Find Depo-SubQ Provera 104 In Stock Today →

Option 4: Transition to Depo-Provera CI (150 mg IM) — Same Active Ingredient, Wider Access

For patients where access to the subcutaneous formulation is a persistent problem, transitioning to Depo-Provera CI (medroxyprogesterone acetate 150 mg intramuscular) may be appropriate. The same active ingredient, same 12–14 week dosing interval, and generics are available — making it more widely stocked at retail pharmacies and typically less expensive. The transition requires no washout period; simply administer Depo-Provera CI at the time the next Depo-SubQ Provera 104 dose would have been due.

When a Patient Has Exceeded the 14-Week Window

If more than 14 weeks have elapsed since the patient's last injection, rule out pregnancy before administering the next dose. Instruct the patient to use a backup non-hormonal contraceptive method until the next injection is confirmed to be safe. Do not re-administer without confirming pregnancy-negative status.

Skip the calls, skip the stress.

Find Depo-SubQ Provera 104 In Stock Today →

50K+

Medications
Found

99%

Success
Rate

6+

Hours saved
on average

Suggested Practice Workflow for Depo-SubQ Provera 104 Patients

At each injection visit, remind the patient to call their pharmacy or contact the office 7–10 days before their next dose is due.

If the patient's pharmacy is out of stock, use medfinder for Providers to identify nearby pharmacies with inventory.

If the patient has exceeded 14 weeks without injection, rule out pregnancy before administering the next dose.

For patients approaching 2 years of use, initiate a counseling conversation about transitioning to an alternative method.

For patients with a history of meningioma: Depo-SubQ Provera 104 is now contraindicated. Transition promptly.

Patient Education Resources

Share our patient-facing shortage update and finder guide with patients who ask about availability. Providing patients with a clear path forward reduces no-show rates driven by inability to fill the prescription before the appointment.